Stockreport

Kamada up 4% on development of coronavirus treatment [Seeking Alpha]

Acasti Pharma, Inc. - Class A  (ACST) 
Last acasti pharma, inc. - class a earnings: 2/14 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: acastipharma.com/investors
PDF Healthcare | On the Move Kamada up 4% on development of coronavirus treatment Mar. 11, 2020 10:14 AM ET Kamada Ltd. (KMDA) Douglas W. House Thinly traded micro cap Kamad [Read more]